Sociodemographic and clinical characteristics of persons who experienced spontaneous hepatitis C viral clearance

• Published in: BMC infectious diseases 2019-07, Vol.19 (1), p.626-626, Article 626
• Main Authors: Kimble, Mabel Michille, Javanbakht, Marjan, Chew, Kara W, Stafylis, Chrysovalantis, He, Di, Ramirez, Samantha, Baik, Yeonsoo, Saab, Sammy, Klausner, Jeffrey D
• Format: Article
• Language: English
• Subjects: Antibodies; Baby boom generation; Chronic kidney failure; Demographic aspects; Epidemiology; Health; Hepatitis C; Hepatitis C virus; Kidney diseases; Medical research; Patient outcomes; Public health; Regression analysis; RNA; Spontaneous clearance; Urban health; Virus inactivation
• ISSN: 1471-2334; 1471-2334
• DOI: 10.1186/s12879-019-4223-9

In the United States Hepatitis C virus (HCV) viral clearance is estimated to range between 20 and 30%. The objective of this study was to estimate the frequency of HCV clearance and identify correlates of viral clearance among patients newly identified as HCV antibody positive in a large urban health system in Los Angeles, California. We identified patients between November 2015 and September 2017 as part of a newly implemented HCV screening and linkage-to-care program at University of California Los Angeles (UCLA) Health System. All patients were eligible for screening, though there were additional efforts to screen patients born between 1945 and 1965. We reviewed Medical records to categorize anti-HCV antibody positive patients as having spontaneously cleared HCV infection (HCV RNA not detected) or not (HCV RNA detected). We excluded those with a prior history of anti-HCV positivity or history of HCV treatment. We compared differences between those with and without detectable HCV RNA using chi-square test, Fisher's exact test, and t-test as appropriate. We assessed factors associated with HCV clearance using logistic regression analysis. Among the 320 patients included in this study, 56% were male. Baby boomers (52-72 years of age) comprised the single largest age group (62%). We found spontaneous HCV clearance in 58% (n = 185). HCV viral clearance was slightly higher among women as compared to men (63% vs. 53%; p value = 0.07) and varied by race/ethnicity: clearance among Blacks/African Americans was 37% vs. 58% among whites (p value = 0.02). After adjusting for age, race/ethnicity, and sex we found that those diagnosed with chronic kidney disease had a tendency of decreased HCV viral clearance (adjusted OR = 0.34; 95% CI 0.14-1.03). Of those patients newly identified as anti-HCV positive, 58% had cleared HCV virus, while the rest showed evidence of active infection. In addition, we found that clearance varied by race/ethnicity and clinical characteristics.